Medicina (Jun 2023)

Epithelial Ovarian Cancer: A Five Year Review

  • Christos Arnaoutoglou,
  • Kalliopi Dampala,
  • Christos Anthoulakis,
  • Evangelos G. Papanikolaou,
  • Ioannis Tentas,
  • Georgios Dragoutsos,
  • Nikolaos Machairiotis,
  • Paul Zarogoulidis,
  • Aristeidis Ioannidis,
  • Dimitris Matthaios,
  • Eleni I. Perdikouri,
  • Dimitrios Giannakidis,
  • Chrysanthi Sardeli,
  • Stamatios Petousis,
  • Panagoula Oikonomou,
  • Christina Nikolaou,
  • Charalampos Charalampidis,
  • Konstantinos Sapalidis

DOI
https://doi.org/10.3390/medicina59071183
Journal volume & issue
Vol. 59, no. 7
p. 1183

Abstract

Read online

Ovarian cancer is a malignant disease that affects thousands of patients every year. Currently, we use surgical techniques for early-stage cancer and chemotherapy treatment combinations for advanced stage cancer. Several novel therapies are currently being investigated, with gene therapy and stem cell therapy being the corner stone of this investigation. We conducted a thorough search on PubMed and gathered up-to-date information regarding epithelial ovarian cancer therapies. We present, in the current review, all novel treatments that were investigated in this field over the past five years, with a particular focus on local treatment.

Keywords